Standard BioTools Inc
LAB1.380USD
-0.090-6.12%
收盘 12/26, 16:00（美东）报价延迟15分钟
529.39M总市值
亏损市盈率 TTM
关于 Standard BioTools Inc 公司
Standard BioTools Inc. develops, manufactures and sells a diversified range of instrumentation, consumables, and services that help scientists and biomedical researchers. The Company's segments include Proteomics and Genomics. The Proteomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of proteins. The Genomics segment includes instruments, consumables, software, and services based upon technologies used in the identification of genes (DNA, RNA) and their functions. The Company works with academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. It offers a diverse range of instrumentation, consumables, and services that generate data across early discovery, translational and clinical research.
Standard BioTools Inc简介
公司代码LAB
公司名称Standard BioTools Inc
上市日期Feb 10, 2011
CEOEgholm (Michael)
员工数量818
证券类型Ordinary Share
年结日Feb 10
公司地址2 Tower Place
城市SOUTH SAN FRANCISCO
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94080
电话16502666000
网址https://www.standardbio.com/
公司代码LAB
上市日期Feb 10, 2011
CEOEgholm (Michael)
Standard BioTools Inc公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
157.01K
+151.54%
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
65.77K
-23.01%
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Mr. Hanjoon Alex Kim
Mr. Hanjoon Alex Kim
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Franklin R. (Frank) Witney, Ph.D.
Dr. Franklin R. (Frank) Witney, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas (Tom) Carey
Mr. Thomas (Tom) Carey
Independent Chairman of the Board
Independent Chairman of the Board
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Fenel M. Eloi
Mr. Fenel M. Eloi
Independent Director
Independent Director
157.01K
+151.54%
Mr. Sean Mackay
Mr. Sean Mackay
Chief Business Officer
Chief Business Officer
65.77K
-23.01%
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Troy Cox
Mr. Troy Cox
Independent Director
Independent Director
--
--
Ms. Kathy Hibbs
Ms. Kathy Hibbs
Independent Director
Independent Director
--
--
Dr. Michael Egholm, Ph.D.
Dr. Michael Egholm, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
收入明细
单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
Consumables
10.46M
48.06%
Services and other revenue
6.09M
27.98%
Instruments
5.21M
23.96%
地区USD
名称
营收
占比
Europe & Middle East & Africa (EMEA)
9.13M
41.94%
Americas
8.69M
39.93%
Asia-Pacific
3.94M
18.13%
业务
地区
业务USD
名称
营收
占比
Consumables
10.46M
48.06%
Services and other revenue
6.09M
27.98%
Instruments
5.21M
23.96%
股东统计
更新时间: 11月15日 周六
更新时间: 11月15日 周六
持股股东
股东类型
持股股东
持股股东
占比
Casdin Capital, LLC
23.09%
Viking Global Investors LP
15.25%
BlackRock Institutional Trust Company, N.A.
5.67%
The Vanguard Group, Inc.
4.47%
MAK Capital One, LLC
4.14%
其他
47.38%
持股股东
持股股东
占比
Casdin Capital, LLC
23.09%
Viking Global Investors LP
15.25%
BlackRock Institutional Trust Company, N.A.
5.67%
The Vanguard Group, Inc.
4.47%
MAK Capital One, LLC
4.14%
其他
47.38%
股东类型
持股股东
占比
Hedge Fund
32.60%
Investment Advisor/Hedge Fund
27.75%
Investment Advisor
14.81%
Individual Investor
2.53%
Research Firm
0.66%
Venture Capital
0.57%
Bank and Trust
0.23%
Pension Fund
0.12%
Insurance Company
0.03%
其他
20.68%
机构持股
更新时间: 10月5日 周日
更新时间: 10月5日 周日
报告期
机构数
持股数
持股占比
持股变动
2025Q3
324
277.96M
72.29%
-27.47M
2025Q2
337
283.64M
74.68%
-28.24M
2025Q1
336
286.88M
75.60%
-24.96M
2024Q4
322
279.84M
75.18%
-22.14M
2024Q3
315
282.67M
78.53%
-14.93M
2024Q2
303
268.49M
74.97%
-14.97M
2024Q1
306
263.03M
71.99%
+131.65M
2023Q4
264
54.09M
66.99%
-14.10M
2023Q3
265
53.37M
67.31%
-13.39M
2023Q2
273
51.56M
65.50%
-19.05M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Casdin Capital, LLC
77.06M
20.17%
+100.00K
+0.13%
Sep 09, 2025
Viking Global Investors LP
58.65M
15.35%
--
--
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
21.79M
5.71%
-554.16K
-2.48%
Jun 30, 2025
The Vanguard Group, Inc.
16.93M
4.43%
-243.51K
-1.42%
Jun 30, 2025
MAK Capital One, LLC
5.60M
1.47%
+2.82M
+101.73%
Jun 30, 2025
Long Focus Capital Management LLC
10.07M
2.64%
+3.37M
+50.30%
Jun 30, 2025
Geode Capital Management, L.L.C.
7.44M
1.95%
+235.68K
+3.27%
Jun 30, 2025
State Street Investment Management (US)
6.30M
1.65%
-57.83K
-0.91%
Jun 30, 2025
Hollow Brook Wealth Management, LLC
5.61M
1.47%
+56.93K
+1.03%
Jun 30, 2025
Morgan Stanley Investment Management Inc. (US)
5.36M
1.4%
-4.51M
-45.67%
Jun 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
Invesco NASDAQ Future Gen 200 ETF
0.51%
ARK Genomic Revolution ETF
0.33%
iShares Micro-Cap ETF
0.07%
iShares Biotechnology ETF
0.04%
iShares Russell 2000 Value ETF
0.03%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.02%
iShares Russell 2000 ETF
0.01%
Global X Russell 2000 ETF
0.01%
Fidelity MSCI Health Care Index ETF
0.01%
查看更多
Invesco NASDAQ Future Gen 200 ETF
占比0.51%
ARK Genomic Revolution ETF
占比0.33%
iShares Micro-Cap ETF
占比0.07%
iShares Biotechnology ETF
占比0.04%
iShares Russell 2000 Value ETF
占比0.03%
ProShares Hedge Replication ETF
占比0.02%
ProShares UltraPro Russell2000
占比0.02%
iShares Russell 2000 ETF
占比0.01%
Global X Russell 2000 ETF
占比0.01%
Fidelity MSCI Health Care Index ETF
占比0.01%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
常见问题
Standard BioTools Inc的前五大股东是谁？
Standard BioTools Inc 的前五大股东如下：
Casdin Capital, LLC持有股份：77.06M，占总股份比例：20.17%。
Viking Global Investors LP持有股份：58.65M，占总股份比例：15.35%。
BlackRock Institutional Trust Company, N.A.持有股份：21.79M，占总股份比例：5.71%。
The Vanguard Group, Inc.持有股份：16.93M，占总股份比例：4.43%。
MAK Capital One, LLC持有股份：5.60M，占总股份比例：1.47%。
Casdin Capital, LLC持有股份：77.06M，占总股份比例：20.17%。
Viking Global Investors LP持有股份：58.65M，占总股份比例：15.35%。
BlackRock Institutional Trust Company, N.A.持有股份：21.79M，占总股份比例：5.71%。
The Vanguard Group, Inc.持有股份：16.93M，占总股份比例：4.43%。
MAK Capital One, LLC持有股份：5.60M，占总股份比例：1.47%。
Standard BioTools Inc的前三大股东类型是什么？
Standard BioTools Inc 的前三大股东类型分别是：
Casdin Capital, LLC
Viking Global Investors LP
BlackRock Institutional Trust Company, N.A.
Casdin Capital, LLC
Viking Global Investors LP
BlackRock Institutional Trust Company, N.A.
有多少机构持有Standard BioTools Inc(LAB)的股份？
截至2025Q3，共有324家机构持有Standard BioTools Inc的股份，合计持有的股份价值约为277.96M，占公司总股份的72.29%。与2025Q2相比，机构持股有所增加，增幅为-2.39%。
哪个业务部门对Standard BioTools Inc的收入贡献最大？
在FY2025Q2，Consumables业务部门对Standard BioTools Inc的收入贡献最大，创收10.46M，占总收入的48.06%。
